Monday, January 17, 2022
wellness India Expo

Editor’s Zone

This space is for the Editor’s critical take on the various issues of importance that have happened during the week. The inside review of various initiatives, developments and the news that mattered most. Few a times, its a bitter pill yet next time a sweet candy, the ‘Editor’s Zone’ acts as an applauder, neutral observer and critic depending on the objectivity.

Feel free to connect with the Editor at [email protected]

Face to Face

“We are constantly strengthening our presence in India”

261
David Schwaas, Director, Marketing & Distribution, Biopharma, Freudenberg Medical shares details about the company's business operations, product offerings, future plans and much more.

Chat with BioVoice

“We aim to grow scale across research, product lines & infrastructure”

171
Gaurav Kaushik, Managing Director & CEO, Meteoric Biopharmaceuticals says that in 2022 his company's focus will be on expanding the production capability and yield of this particular strain of probiotics..................

R&D

Events